Sara R. Neves-Martins
Coimbra, 3000548, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Journal: International journal of molecular sciences
Published: March 31, 2023
Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.
Journal: International journal of molecular sciences
Published: August 20, 2022
Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
Journal: Pharmacological research
Published: July 23, 2018
IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
Journal: Cancer letters
Published: September 14, 2017
Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
Journal: Cancer chemotherapy and pharmacology
Published: April 27, 2017
Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling.
Journal: Cancer letters
Published: September 16, 2015
Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4.
Journal: Journal of cellular physiology
Published: June 22, 2015
Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Journal: Life sciences
Published: December 29, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026